EIKEN CHEMICAL manufactures and markets a range of products used in the diagnosis and treatment of microbial infections. These include culture media, bacterial identification kits, and reagents for antibiotic susceptibility tests.

Uropaper III ‘Eiken’, an urinalysis test strip that allows evaluation of 10 compounds/metabolites (including protein, glucose, urobilinogen, and occult blood), is widely used in hospitals and reference laboratories for diagnosis and medical checkups.
Uropaper III ‘Eiken’ is a product designed for use with automated urine analyzers.

EIKEN CHEMICAL provides a broad range of clinical chemistry reagents for various automated clinical analyzers used in the evaluation of liver function and measurement of lipids, whose relationship to lifestyle-related diseases is becoming widely recognized.

EIKEN CHEMICAL developed and supplies the OC-Hemodia ‘Eiken’ to detect fecal occult blood when screening for early identification of colon cancer; Lumispot ‘Eiken’ HCV antigen; reagents for the diagnosis of infectious diseases; and reagents for enzyme immunoassay for hormones and other markers for clinical diagnosis.

EIKEN CHEMICAL has developed and markets a variety of automated clinical analyzers to meet the demand for automation in clinical laboratory testing.

EIKEN CHEMICAL developed and supplies industrial microbiological reagents for food and environment, and variety of equipments.

In 1998, EIKEN CHEMICAL developed an innovative nucleic acid amplification method, called “LAMP” (Loop-mediated Isothermal Amplification).

We are strongly committed to in-house R&D projects in such fields as medicine, agriculture, food production and processing, animal husbandry, and environmental protection.

We are also considering potential business alliances, both within Japan and offshore.